FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
19 letters match. Newest first.
-
DevicesNext Medical Products Company, LLC
FDA warns Next Medical Products that its ultrasound gels were contaminated and made without required quality controls or clearance.
High risk -
DevicesPro-Optics, LLC
FDA warned Pro-Optics about unapproved material and color changes to contact lens cases and quality system failures.
Medium -
DevicesPeter Schiff Enterprises
FDA warns Peter Schiff Enterprises over unapproved cardiac devices and serious quality system failures.
High risk -
BiologicsTides Medical LLC
FDA warns Tides Medical over APLICOR 3D wound device sold without approval, exemption, or required FDA notice.
High risk -
DevicesAdvance-Esthetic LLC
FDA says Advance-Esthetic markets three Zemits body-contouring devices without the required FDA clearance or approval.
Medium -
DevicesSpecialty Health Products CO, LLC
Specialty Health Products was cited for quality-system, unapproved marketing, and listing violations for its Hydro-San and Aqua Cleanse colonic irrigation devices.
High risk -
DevicesNihon Kohden Digital Health Solutions, LLC
FDA says Nihon Kohden Digital Health Solutions sold an uncleared monitor software change that can silence life-threatening alarms.
High risk -
DevicesZIIP, Inc.
FDA warns ZIIP over quality-system violations and unapproved marketing of HALO 2.0, DOT, and gels.
High risk -
DevicesSkytron, LLC
Skytron marketed four UV disinfection devices without FDA clearance or approval and kept unapproved medical claims after promising to remove them.
High risk -
Devices3B Medical, Inc. dba Reach Health, Inc.
FDA warns Reach Health over unapproved APAP use change and complaint/CAPA failures.
High risk -
BiologicsEstar Technologies Ltd
FDA warns Estar Technologies over selling seven unapproved PRP/PRF device kits in the U.S. without clearance or approval.
High risk -
Biologics4U Health
FDA says 4U Health sells an unapproved HIV dried blood spot self-collection kit, making it adulterated and misbranded.
High risk -
DevicesLonghorn Vaccines and Diagnostics LLC
Longhorn Vaccines and Diagnostics sold its PrimeStore MTM sample transport device without required quality controls or clearance for claims beyond its approved uses.
High risk -
DevicesDiasol, Inc.
Diasol sold unapproved citric acid hemodialysis disinfectants and had quality system violations, FDA says.
High risk -
DevicesExThera Medical Corporation
ExThera shipped Seraph 100 blood filters for compassionate use without FDA approval and promoted them as approved.
High risk -
BiologicsGermaphobix
FDA warns Germaphobix that its unapproved HIV dried blood spot self-collection kit is adulterated and misbranded.
High risk -
DevicesASP Global, LLC. dba Anatomy Supply Partners, LLC.
FDA cites ASP Global for quality-system, reporting, and unapproved-change violations involving Safe-T-Fill blood collection devices.
High risk -
DevicesRobbins Instruments, LLC
Medical Device/Misbranded/Unapproved Device/Quality System Regulation
-
DevicesAMCO International Manufacturing & Design, Inc.
Unapproved Device Violation